Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,918,522
-
Share change
-
+61,827
-
Total reported value
-
$25,143,027
-
Put/Call ratio
-
117%
-
Price per share
-
$2.11
-
Number of holders
-
71
-
Value change
-
-$3,006,763
-
Number of buys
-
43
-
Number of sells
-
25
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q4 2022
As of 31 Dec 2022,
Humacyte, Inc. - COM (HUMA) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,918,522 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Prescott General Partners LLC, NORTHERN TRUST CORP, STATE STREET CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, LPL Financial LLC, Bank of New York Mellon Corp, and Nuveen Asset Management, LLC.
This page lists
71
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.